Biotech Stories

Global Stories

Biotech stories

Persistent wins Databricks healthcare & life sciences

The new specialisation should help healthcare and life sciences firms use governed AI and data tools to speed trials, discovery and patient insights.

By Mark Tarre • 4 min read • This month

Data Protection

AI use in life sciences focused on augmentation - for now

AI in life sciences is boosting workflows rather than replacing scientists, as firms navigate regulation, data risks and uneven adoption across markets.

By David Shilovsky • 5 min read • This month

Document Management

i-GENTIC expands GENIE to cover FDA compliance lifecycle

Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.

By Joseph Gabriel Lagonsin • 5 min read • This month

Data Analytics

OpenAI launches GPT-Rosalind for life sciences research

Research teams could see faster target discovery as OpenAI opens GPT-Rosalind to qualified US customers for biology and drug discovery work.

By Mark Tarre • 4 min read • Last month

Quantum Computing

Kvantify hires Dr David Siebert to lead global business development

The Danish quantum software firm is pushing into life sciences now, adding senior hires and partners to sell hybrid tools before the market matures.

By Sofiah Nichole Salivio • 4 min read • Last month

Semiconductors

US AI megadeals drive global VC to USD $331 billion

A handful of US artificial intelligence megadeals pushed global venture capital investment to USD $330.9 billion in the first quarter, KPMG said.

By Karen Joy Bacudo • 4 min read • Last month

Digital Transformation

ACTO launches role-based AI SuperAgents for Life Sciences

Pharmaceutical field teams could cut hours of searching to seconds as ACTO's new system routes approved information through compliance checks.

By Joseph Gabriel Lagonsin • 4 min read • Last month

Disaster Recovery

Iran-linked wiper cyber attack cripples Stryker plants

Iran-linked wiper cyber attack cripples Stryker plants, disrupting implant production and locking thousands of staff out of global networks.

By Shannon Williams • 5 min read • Fri, 13th Mar 2026

Risk & Compliance

Diversity will define the next era of biotech infrastructure

Biotech's next leaders will be defined less by scientific breakthroughs and more by diverse teams building resilient clinical infrastructure.

By Pam Ramali • 4 min read • Tue, 3rd Mar 2026

Stories from Other Regions

Biotech stories

Robotics

Feds back GTA AI projects with CAD $16.5M investment

The grants are set to speed the rollout of AI tools across healthcare, manufacturing and finance, helping GTA firms reach market sooner.

By Jake MacAndrew • 3 min read • 3 days ago

Health Technologies

Canadian healthtech saw $900M VC funding decline in 2025

Healthtech startups are finding it harder to scale as weaker exits and tighter liquidity help drive Canadian VC investment down to CAD $1 billion in 2025.

By Jake MacAndrew • 4 min read • This month

Agricultural Technology

Kurraba signs first tenants for Sydney life sciences hub

The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.

By Joseph Gabriel Lagonsin • 5 min read • This month

Health Technologies

BioOrbit raises GBP £9.8 million for drugmaking in space

The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.

By Karen Joy Bacudo • 5 min read • This month

Artificial Intelligence

MaRS expert panel divided on Canada's health future

Canada’s health tech sector is struggling to turn strong research into commercial scale, as panellists split over whether policy or private capital should lead.

By Jake MacAndrew • 4 min read • Last month

Health Technologies

British Business Bank backs Apposite with GBP £100m

The move gives UK life sciences firms a new source of scale-up capital as a funding gap has left many promising businesses short of backing.

By Karen Joy Bacudo • 4 min read • Last month

Robotics

Helical raises USD $10 million to expand virtual AI lab

The London biotech startup will use new funding to broaden deployments at major drugmakers, including Pfizer, and speed research decisions.

By Sofiah Nichole Salivio • 4 min read • Last month

Manufacturing

Feds back Vancouver life science sector with CAD $127M

The funding will help expand Vancouver research, manufacturing and clinical trials, with hundreds of jobs and student co-op places expected to follow.

By Jake MacAndrew • 3 min read • Last month